Patents by Inventor Frances C. Lawyer

Frances C. Lawyer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5789224
    Abstract: Recombinant DNA sequences encoding the DNA polymerase activity of Thermus thermophilus can be used to construct recombinant vectors and transformed host cells for production of the activity. T. thermophilus DNA polymerase is an .about.94 kDa protein especially useful in the DNA amplification procedure known as the polymerase chain reaction.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: August 4, 1998
    Assignee: Roche Molecular Systems, Inc.
    Inventors: David H. Gelfand, Frances C. Lawyer, Susanne Stoffel
  • Patent number: 5624833
    Abstract: A purified thermostable enzyme is derived from the eubacterium Thermotoga maritima. The enzyme has a molecular weight as determined by gel electrophoresis of about 97 kilodaltons and DNA polymerase I activity. The enzyme can be produced from native or recombinant host cells and can be used with primers and nucleoside triphosphates in a temperature-cycling chain reaction where at least one nucleic acid sequence is amplified in quantity from an existing sequence.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: April 29, 1997
    Assignee: Hoffmann-La Roche Inc.
    Inventors: David H. Gelfand, Frances C. Lawyer, Susanne Stoffel
  • Patent number: 5618711
    Abstract: Recombinant DNA sequences encoding the DNA polymerase activity of Thermus thermophilus can be used to construct recombinant vectors and transformed host cells for production of the activity. T. thermophilus DNA polymerase is an .about.94 kDa protein especially useful in the DNA amplification procedure known as the polymerase chain reaction.
    Type: Grant
    Filed: February 6, 1995
    Date of Patent: April 8, 1997
    Assignee: Hoffmann-La Roche Inc.
    Inventors: David H. Gelfand, Frances C. Lawyer, Susanne Stoffel
  • Patent number: 5420029
    Abstract: A purified thermostable enzyme is derived from the eubacterium Thermotoga maritima. The enzyme has a molecular weight as determined by gel electrophoresis of about 97 kilodaltons and DNA polymerase I activity. The enzyme can be produced from native or recombinant host cells and can be used with primers and nucleoside triphosphates in a temperature-cycling chain reaction where at least one nucleic acid sequence is amplified in quantity from an existing sequence.
    Type: Grant
    Filed: February 3, 1993
    Date of Patent: May 30, 1995
    Assignee: Hoffmann-La Roche Inc.
    Inventors: David H. Gelfand, Frances C. Lawyer, Susanne Stoffel
  • Patent number: 5374553
    Abstract: A purified thermostable enzyme is derived from the eubacterium Thermotoga maritima. The enzyme has a molecular weight of about 97 kilodaltons and DNA polymerase I activity. The enzyme can be produced from native or recombinant host cells and can be used with primers and nucleoside triphosphates in a temperaturecycling chain reaction where at least one nucleic acid sequence is amplified in quantity from an existing sequence.
    Type: Grant
    Filed: August 13, 1990
    Date of Patent: December 20, 1994
    Assignee: Hoffmann-La Roche Inc.
    Inventors: David H. Gelfand, Frances C. Lawyer
  • Patent number: 5116750
    Abstract: A novel a selectable fusion protein having aminoglycoside phosphotransferase activity is disclosed. The marker comprises the coding sequences for aminoglycoside phosphotransferase I (APH-I) which has been modified and truncated so as to render its use in recombinant vectors more convenient. The modified, truncated sequence (mtAPH-I) gene is capable, upon expression, of conferring resistance to a number of antibiotics on the host. One of these antibiotics, G418, is toxic to eucaryotic as well as procaryotic hosts. Also disclosed are methods of constructing fusion proteins having N-terminal sequences corresponding to a desired peptide sequence, and C-terminal sequences comprising the amino acids encoded by mtAPH-I. The preferred N-terminal sequences are the first 11 amino acids of .beta.-isopropyl malate dehydrogenase, and the first 7 amino acids of yeast enolase.
    Type: Grant
    Filed: July 22, 1988
    Date of Patent: May 26, 1992
    Assignee: Cetus Corporation
    Inventors: David H. Gelfand, Frances C. Lawyer, Susanne Stoffel
  • Patent number: 5079352
    Abstract: Recombinant DNA vectors that encode a thermostable DNA polymerase are useful in the recombinant production of thermostable DNA polymerase. The recombinant thermostable polymerase is preferred for use in the production of DNA in a polymerase chain reaction. Especially useful vectors encode the .about.94,000 dalton thermostable DNA polymerase from thermus aquaticus.
    Type: Grant
    Filed: May 15, 1990
    Date of Patent: January 7, 1992
    Assignee: Cetus Corporation
    Inventors: David H. Gelfand, Susanne Stoffel, Frances C. Lawyer, Randall K. Saiki
  • Patent number: 4889818
    Abstract: A purified thermostable enzyme is obtained that has unique characteristics. Preferably the enzyme is isolated from the Thermus aquaticus species and has a molecular weight of about 86,000-90,000 daltons. The thermostable enzyme may be native or recombinant and may be used in a temperature-cycling chain reaction wherein at least one nucleic acid sequence is amplified in quantity from an existing sequence with the aid of selected primers and nucleotide triphosphates. The enzyme is preferably stored in a buffer of non-ionic detergents that lends stability to the enzyme.
    Type: Grant
    Filed: June 17, 1987
    Date of Patent: December 26, 1989
    Assignee: Cetus Corporation
    Inventors: David H. Gelfand, Susanne Stoffel, Frances C. Lawyer, Randall K. Saiki
  • Patent number: 4870013
    Abstract: Expression vectors containing coding sequences under the control of SV40 early and RSV promoters are disclosed as useful in producing proteins in saccharomyces yeasts. Construction of such vectors, and their use in yeast transformations are described.
    Type: Grant
    Filed: May 18, 1988
    Date of Patent: September 26, 1989
    Assignee: Cetus Corporation
    Inventors: David H. Gelfand, Frances C. Lawyer, Susanne Stoffel
  • Patent number: 4830962
    Abstract: Recombinant vectors which are effective in expressing DNA sequences encoding specific fragments of diphtheria toxins at high levels in recombinant host cells are disclosed. Both a fragment consisting of the enzymatically active A chain of diphtheria toxin and a fragment consisting of both the A portion and a B portion partial sequence are constructed by use of this recombinant vector.
    Type: Grant
    Filed: February 9, 1984
    Date of Patent: May 16, 1989
    Assignee: Cetus Corporation
    Inventors: David H. Gelfand, Lawrence I. Greenfield, Frances C. Lawyer
  • Patent number: 4784949
    Abstract: A novel universal dominant selectable marker cassette is disclosed. The marker comprises the coding sequences for aminoglycoside phosphotransferase I (APH-I) which has been modified and truncated so as to render its use in recombinant vectors more convenient. The modified, truncated sequence (mtAPH-I) gene is capable, upon expression, of conferring resistance to a number of antibiotics on the host. One of these antibiotics, G418, is toxic to eucaryotic as well as procaryotic hosts. Also disclosed are methods of constructing fusion proteins having N-terminal sequences corresponding to a desired peptide sequence, and C-terminal sequences comprising the amino acids encoded by mtAPH-I.
    Type: Grant
    Filed: April 19, 1984
    Date of Patent: November 15, 1988
    Assignee: Cetus Corporation
    Inventors: David H. Gelfand, Frances C. Lawyer, Susanne Stoffel
  • Patent number: 4711845
    Abstract: Two types of convenient portable control cassettes for the expression of protein encoding sequences in procaryotes are disclosed. Both cassettes comprise the P.sub.L promoter from lambda phage, which is controllable by means of a temperature sensitive repressor, operably linked to the ribosome binding site for N-gene (N.sub.RBS). In one embodiment, this cassette is bordered by restriction sites upstream of the P.sub.L promoter and immediately downstream from the N.sub.RBS permitting the insertion of a desired sequence containing its own start codon downstream from the cassette. The other embodiment contains an ATG start codon within the cassette and has a restriction site immediately 3' of the start codon.
    Type: Grant
    Filed: December 24, 1984
    Date of Patent: December 8, 1987
    Assignee: Cetus Corporation
    Inventors: David H. Gelfand, Frances C. Lawyer